2nd Quarter - Termination

BALLARD PARTNERS for GENETIX BIOTHERAPEUTICS INC.

Firm
Client
Income
$80,000
Expenses
—
Terminated
May 31, 2026

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 15, 2026 $120,000 Replaced
2nd Quarter - Termination (this page) Oct 16, 2026 $80,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocacy regarding an FDA issue.

LobbyistCovered position, as disclosed
ALISON ANWAY LA to Senator Pat Roberts 2006-2010
BRIAN BALLARD —
TOLA THOMPSON Communications Director and Senior Legislative Assistant to U.S. Representative Carrie Meek (1993-2002); Chief of Staff to U.S. Representative Al Lawson (2017-2021)

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.